Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-04-26FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for Nortriptyline Hydrochloride (PAI Pharma) under ANDA075606. The action grants approval of the…
-
FDA approval · 2010-04-22FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride tablets from Aurobindo Pharma Limited.
-
FDA approval · 2010-04-16FDA Approved: IMIPRAMINE PAMOATE — Original Application (Hikma Pharmaceuticals USA Inc)
FDA approves the original application for Imipramine Pamoate (generic) from Hikma Pharmaceuticals USA Inc. for use in treating depression an…
-
FDA approval · 2010-04-16FDA Approved: IMIPRAMINE PAMOATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' imipramine pamoate as an Original Application (generic) under the ANDA process for the same indications …
-
FDA approval · 2010-04-08FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for Bupropion Hydrochloride from Aurobindo Pharma Limited. This approval adds a generic option for the indica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-07Clinical Trial Update: A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder. [Phase 3]
Phase 3 randomized, double-blind study comparing trazodone Contramid OAD to placebo in adults with unipolar major depressive disorder; resul…
-
FDA approval · 2010-04-07FDA Approved: VENLAFAXINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for Venlafaxine hydrochloride, a generic version of venlafaxine.
-
FDA approval · 2010-04-06FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for generic bupropion hydrochloride tablets. The product is indicated for m…
-
FDA approval · 2010-04-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
The FDA approved a supplemental application for Bupropion hydrochloride from Epic Pharma LLC, granting approval for this generic product.
-
CLINICAL_TRIALS trial_result · 2010-04-01Clinical Trial Update: Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder [Phase 3]
Phase 3 trial assessing the efficacy and safety of Seroquel SR for major depressive disorder has completed, with results posted.
-
FDA approval · 2010-03-25FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental ANDA for Desipramine hydrochloride from Actavis Pharma, Inc., supporting the generic product's approval.
-
FDA approval · 2010-03-25FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Desipramine Hydrochloride from Actavis Pharma, Inc.
-
FDA approval · 2010-03-25FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Desipramine Hydrochloride from Actavis Pharma, enabling the marketing of a generic version.
-
FDA approval · 2010-03-25FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for paroxetine hydrochloride hemihydrate from Mylan Pharmaceuticals Inc., advancing the generic …
-
FDA approval · 2010-03-25FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for paroxetine hydrochloride from Apotex Corp., granting approval for an additional generic product.
-
FDA approval · 2010-03-22FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved a generic version of fluoxetine hydrochloride (an SSRI) from Dr. Reddy's Laboratories Limited under an Original Application (AN…
-
CLINICAL_TRIALS research · 2010-03-18Clinical Trial Update: Antenatal Relaxation Group for Anxiety and Depression Management [NA]
Clinical trial update for an Antenatal Relaxation Group addressing anxiety and depression in pregnancy, sponsored by the University of Saska…
-
FDA approval · 2010-03-15FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690.
-
FDA approval · 2010-03-11FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application submitted by BluePoint Laboratories for venlafaxine (venlafaxine hydrochloride) as a generic product…
-
FDA approval · 2010-03-11FDA Approved: IMIPRAMINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approval of a new generic imipramine hydrochloride product from Lupin Pharmaceuticals (ANDA 090441).
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults
A completed US trial update evaluating whether exposure to antidepressants influences the risk of suicide attempts requiring medical interve…
-
CLINICAL_TRIALS trial_result · 2010-03-04Clinical Trial Update: Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents [Phase 4]
This is a post-marketing Phase 4 clinical study evaluating fluvoxamine maleate for treating major depressive disorder in children and adoles…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Preventing Depression Recurrence in Diabetes [Phase 4]
A Phase 4 clinical trial evaluating prevention of depression recurrence in people with diabetes has completed.
-
CLINICAL_TRIALS research · 2010-03-02Clinical Trial Update: Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder [Phase 1, Phase 2]
This entry reports a completed Phase 1/2 clinical trial evaluating BMS-562086 in outpatients with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Depression In Juvenile Diabetics [NA]
This Clinical Trial Update reports that the study on Depression in Juvenile Diabetics has completed.